The abstract does not include the specifics for these endpoints, only stating that there were significant improvements. Eli Lilly previously disclosed in a press release, that they expected patients using tirzepatide to lose between 18-20% of their body weight
However, as we age, factors like pollution, stress, and unhealthy lifestyles deplete our Glutathione levels
The good news is these medications, semaglutide, the active ingredient in Ozempic and Wegovy, or tirzepatide, the active ingredient in Mounjaro, are part of a class of medications, GLP-1 receptor agonists, that have been around for over 20 years so we know the side effects, mostly gastrointestinal in nature (nausea, vomiting, constipation and diarrhea)
Wait until side effects subside